<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-WVXKCDK" height="0" width="0" style="display:none;visibility:hidden"></iframe>
#FutureReadyHealthcare
Who We Are
Investor Relations
News
Careers
Contact Us
XyloCor chooses Indegene's MME to assess PRMA landscape for refractory angina
Back to Videos
Related Insights
4:05
Cosette Pharmaceuticals chooses Indegene’s MME to assess market for 8 new cardiovascular therapies
1:01:37
Webinar: The Metaverse - What it means for life sciences companies
7.01
Learnings from MAPS 2022 Global Annual Meeting